A decrease of RANKL release, most likely associated with a reduction of bone resorption by OC, has been shown after radon treatment of RA patients (Figure 2; arrow 3) [116] and is claimed also for AS patients [106]. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.